1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Immunohistochemistry
  • 1.2.3 Molecular Diagnostics
• 1.3 Market by Application
  • 1.3.1 Global Companion Diagnostic Technologies Market Share by Application: 2020 VS 2026
  • 1.3.2 Oncology
  • 1.3.3 Cardiovascular
  • 1.3.4 Central Nervous System
  • 1.3.5 Auto immune & Inflammation
  • 1.3.6 Virology
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Companion Diagnostic Technologies Market Perspective (2015-2026)
• 2.2 Global Companion Diagnostic Technologies Growth Trends by Regions
  • 2.2.1 Companion Diagnostic Technologies Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Companion Diagnostic Technologies Historic Market Share by Regions (2015-2020)
  • 2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Companion Diagnostic Technologies Players by Market Size
  • 3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2015-2020)
  • 3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2015-2020)
• 3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
• 3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
  • 3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2019
• 3.5 Key Players Companion Diagnostic Technologies Area Served
• 3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
• 3.7 Date of Enter into Companion Diagnostic Technologies Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Technologies Breakdown Data by Type (2015-2026)

• 4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2015-2020)
• 4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2021-2026)

5 Companion Diagnostic Technologies Breakdown Data by Application (2015-2026)

• 5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2015-2020)
• 5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Companion Diagnostic Technologies Market Size (2015-2026)
• 6.2 North America Companion Diagnostic Technologies Market Size by Type (2015-2020)
• 6.3 North America Companion Diagnostic Technologies Market Size by Application (2015-2020)
• 6.4 North America Companion Diagnostic Technologies Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Companion Diagnostic Technologies Market Size (2015-2026)
• 7.2 Europe Companion Diagnostic Technologies Market Size by Type (2015-2020)
• 7.3 Europe Companion Diagnostic Technologies Market Size by Application (2015-2020)
• 7.4 Europe Companion Diagnostic Technologies Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Companion Diagnostic Technologies Market Size (2015-2026)
• 8.2 China Companion Diagnostic Technologies Market Size by Type (2015-2020)
• 8.3 China Companion Diagnostic Technologies Market Size by Application (2015-2020)
• 8.4 China Companion Diagnostic Technologies Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Companion Diagnostic Technologies Market Size (2015-2026)
• 9.2 Japan Companion Diagnostic Technologies Market Size by Type (2015-2020)
• 9.3 Japan Companion Diagnostic Technologies Market Size by Application (2015-2020)
• 9.4 Japan Companion Diagnostic Technologies Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Companion Diagnostic Technologies Market Size (2015-2026)
• 10.2 Southeast Asia Companion Diagnostic Technologies Market Size by Type (2015-2020)
• 10.3 Southeast Asia Companion Diagnostic Technologies Market Size by Application (2015-2020)
• 10.4 Southeast Asia Companion Diagnostic Technologies Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Dako (Agilent Technologies)
  • 11.1.1 Dako (Agilent Technologies) Company Details
  • 11.1.2 Dako (Agilent Technologies) Business Overview
  • 11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
  • 11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2015-2020))
  • 11.1.5 Dako (Agilent Technologies) Recent Development
• 11.2 Qiagen
  • 11.2.1 Qiagen Company Details
  • 11.2.2 Qiagen Business Overview
  • 11.2.3 Qiagen Companion Diagnostic Technologies Introduction
  • 11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.2.5 Qiagen Recent Development
• 11.3 Roche
  • 11.3.1 Roche Company Details
  • 11.3.2 Roche Business Overview
  • 11.3.3 Roche Companion Diagnostic Technologies Introduction
  • 11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.3.5 Roche Recent Development
• 11.4 Abbott Laboratories
  • 11.4.1 Abbott Laboratories Company Details
  • 11.4.2 Abbott Laboratories Business Overview
  • 11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
  • 11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.4.5 Abbott Laboratories Recent Development
• 11.5 Thermo Fisher Scientific
  • 11.5.1 Thermo Fisher Scientific Company Details
  • 11.5.2 Thermo Fisher Scientific Business Overview
  • 11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
  • 11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.5.5 Thermo Fisher Scientific Recent Development
• 11.6 bioMerieux
  • 11.6.1 bioMerieux Company Details
  • 11.6.2 bioMerieux Business Overview
  • 11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
  • 11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.6.5 bioMerieux Recent Development
• 11.7 Myriad Genetics
  • 11.7.1 Myriad Genetics Company Details
  • 11.7.2 Myriad Genetics Business Overview
  • 11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
  • 11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.7.5 Myriad Genetics Recent Development
• 11.8 Resonance Health Ltd.
  • 11.8.1 Resonance Health Ltd. Company Details
  • 11.8.2 Resonance Health Ltd. Business Overview
  • 11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
  • 11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.8.5 Resonance Health Ltd. Recent Development
• 11.9 Leica Microsystems
  • 11.9.1 Leica Microsystems Company Details
  • 11.9.2 Leica Microsystems Business Overview
  • 11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
  • 11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.9.5 Leica Microsystems Recent Development
• 11.10 Danaher
  • 11.10.1 Danaher Company Details
  • 11.10.2 Danaher Business Overview
  • 11.10.3 Danaher Companion Diagnostic Technologies Introduction
  • 11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2015-2020)
  • 11.10.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Companion Diagnostic Technologies Scope and Market Size
Companion Diagnostic Technologies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Immunohistochemistry
Molecular Diagnostics

Market segment by Application, split into
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others

Based on regional and country-level analysis, the Companion Diagnostic Technologies market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Companion Diagnostic Technologies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher